1,036
Views
22
CrossRef citations to date
0
Altmetric
Original Articles

Development and evaluation of targeting ligand-anchored CNTs as prospective targeted drug delivery system

, , &
Pages 242-250 | Received 24 Sep 2015, Accepted 22 Jan 2016, Published online: 18 Feb 2016

References

  • Agarwal A, Gupta U, Asthana A, Jain NK. 2009. Dextran conjugated dendritic nanoconstructs as potential vectors for anti-cancer agent. Biomaterials. 30:3588–3596.
  • Allard-Vannier E, Cohen-Jonathan S, Gautier J, Herve-Aubert K, Munnier E, Souce M, et al. 2012. Pegylated magnetic nanocarriers for doxorubicin delivery: a quantitative determination of stealthiness in vitro and in vivo. Euro J Pharm Biopharm. 81:498–505.
  • Bethune D, Klang C, Vries D, Gorman M, Savoy G, Vazquez RJ, Beyers R. 1993. Cobalt-catalysed growth of carbon nanotubes with single-atomic-layer walls. Nature. 363:605–607.
  • Bhadra D, Bhadra S, Jain S, Jain N. 2003. A PEGylated dendritic nanoparticulate carrier of fluorouracil. Int J Pharm. 257:111–124.
  • Cao N, Feng SS. 2008. Doxorubicin conjugated to D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS): conjugation chemistry, characterization, in vitro and in vivo evaluation. Biomaterials. 29:3856–3865.
  • Chiang I, Brinson B, Huang A, Willis P, Bronikowski M, Margrave J, Smalley R, Hauge R. 2001. Purification and characterization of single-wall carbon nanotubes (SWNTs) obtained from the gas-phase decomposition of CO (HiPco process). J Phys Chem B. 5:8297–8301.
  • Das M, Datir SR, Singh RP, Jain S. 2013. Augmented anticancer activity of a targeted, intracellularly activatable, theranostic nanomedicine based on fluorescent and radiolabeled, methotrexate-folic acid-multiwalled carbon nanotube conjugate. Mole Pharm. 10:2543–2557.
  • Datsyuk V, Kalyva M, Papagelis K, Parthenios J, Tasis D, Siokou A, Kallitsis I, Galiotis C. 2008. Chemical oxidation of multiwalled carbon nanotubes. Carbon. 46:833–840.
  • De la Cruz EF, Zheng Y, Torres E, Li W, Song W, Burugapalli K. 2012. Zeta potential of modified multi-walled carbon nanotubes in presence of poly (vinyl alcohol) hydrogel. Int J Electrochem Sci. 7:3577–3590.
  • Hirlekar R, Yamagar M, Garse H, Vij M, Kadam V. 2009. Carbon nanotubes and its applications: a review. Asian J Pharm Clinl Res. 2:17–27.
  • Huang H, Yuan Q, Shah J, Misra R. 2011. A new family of folate-decorated and carbon nanotube-mediated drug delivery system: synthesis and drug delivery response. Adv Drug Delivery Rev. 63:1332–1339.
  • Huczko A. 2002. Synthesis of aligned carbon nanotubes. Appl Phys A. 74:617–638.
  • Iijima S, Ichihashi T. 1993. Single-shell carbon nanotubes of 1-nm diameter. Nature. 363:603–605.
  • Iijima S. 1991. Helical microtubules of graphitic carbon. Nature. 354:56–58.
  • Jain AK, Dubey V, Mehra NK, Lodhi N, Nahar M, Mishra DK, Jain NK. 2009. Carbohydrate-conjugated multiwalled carbon nanotubes: development and characterization. Nanomed Nanotechnol Biol Med. 5:432–442.
  • Kayat J, Mehra NK, Gajbhiye V, Jain NK. 2016. Drug targeting to arthritic region via folic acid appended surface engineered multi-walled carbon nanotubes. J Drug Target. 24:318–327.
  • Li CC, Lin JL, Huang SJ, Lee JT, Chen CH. 2007. A new and acid-exclusive method for dispersing carbon multi-walled nanotubes in aqueous suspensions. Colloid Surface A. 297:275–281.
  • Lodhi N, Mehra NK, Jain NK. 2013. Development and characterization of dexamethasone mesylate anchored on multi walled carbon nanotubes. J Drug Target. 2013 21:67–76.
  • Mattos ACD, Khalil NM, Mainardes RM. 2013. Development and validation of an HPLC method for the determination of fluorouracil in polymeric nanoparticles. Brazilian J Pharma Sci. 49:117–126.
  • Mehra NK, Jain AK, Lodhi N, Raj R, Dubey V, Mishra D, et al. 2008. Challenges in the use of carbon nanotubes for biomedical applications. Crit Rev Ther Drug Carr Syst. 25:169–206.
  • Mehra NK, Jain K, Jain NK. 2015. Pharmaceutical and biomedical application of surface engineered carbon nanotubes. Drug Discov Today. 20:750–756.
  • Mehra NK Jain N. 2013. Development, characterization and cancer targeting potential of surface engineered carbon nanotubes. J Drug Target. 21:745–758.
  • Mehra NK, Jain NK. 2015a. Cancer targeting propensity of folate conjugated surface engineered multi-walled carbon nanotubes. Colloid Surf B. 132:17–26.
  • Mehra NK, Jain NK. 2015b. One platform comparison of estrone and folic acid anchored surface Engineered MWCNTs for doxorubicin delivery. Mol Pharm. 12:630–643.
  • Mehra NK, Jain NK. 2016. Multifunctional hybrid-carbon nanotubes: new horizon in drug delivery and targeting. J Drug Target. 24:294–308.
  • Mehra NK, Palakurthi S. 2015. Interactions between carbon nanotubes and bioactives: a drug delivery perspective. Drug Discov Today. doi: 10.1016/j.drudis.2015.11.011.
  • Mehra NK, Verma AK, Mishra P, Jain N. 2014. The cancer targeting potential of d-α-tocopheryl polyethylene glycol 1000 succinate tethered multi walled carbon nanotubes. Biomaterials. 35:4573–4588.
  • Mittal V, Patel S, Sheth S. 2010. Development and characterization of folate targeted nanoparticle drug delivery system. Int J Pharm Bio Sci. 1:1–2.
  • Pruthi J, Mehra NK, Jain NK. 2012. Macrophages targeting of amphotericin B through mannosylated multiwalled carbon nanotubes. J Drug Target. 20:593–604.
  • Ren J, Shen S, Wang D, Xi Z, Guo L, Pang Z, et al. 2012. The targeted delivery of anticancer drugs to brain glioma by PEGylated oxidized multi-walled carbon nanotubes modified with angiopep-2. Biomaterials. 33:3324–3333.
  • Sharma P, Mehra NK, Jain K, Jain NK. 2015. Biomedical applications of carbon nanotubes: a critical review. Curr Drug Deliv. In press.
  • Shi X, Wang SH, Shen M, Antwerp ME, Chen X, Li C, et al. 2009. Multifunctional dendrimer-modified multiwalled carbon nanotubes: synthesis, characterization, and in vitro cancer cell targeting and imaging. Biomacromolecules. 10:1744–1750.
  • Singh P, Gupta U, Asthana A, Jain NK. 2008. Folate and folate-PEG-PAMAM dendrimers: synthesis, characterization, and targeted anticancer drug delivery potential in tumor bearing mice. Bioconjug Chem. 19:2239–2252.
  • Spinato C, Giust D, Vacchi IA, Menard-Moyon C, Kostarelos K, Bianco A. 2016. Different chemical strategies to aminate oxidized multi-walled carbon nanotubes for siRNA complexation and delivery. J Mater Chem B. 4:431–441.
  • Tavakolifard S, Biazar E, Pourshamsian K, Moslemin MH. 2015. Synthesis and evaluation of single-wall carbon nanotubes-paclitaxel-folic acid conjugate as an anti-cancer targeting agent. Artif Cells, Nanomed Biotechnol. doi: 10.3109/21691401.2015.1019670.
  • Yoong SL, Wong BS, Zhou QL, Chin CF, Li J, Venkatesan T, et al. 2014. Enhanced cytotoxicity to cancer cells by mitochondria-targeting MWCNTs containing platinum(IV) prodrug of cisplatin. Biomaterials. 35:748–759.
  • Yudianti R, Onggo H, Sudirman YS, Iwata T, Azuma JI. 2011. Analysis of functional group sited on multi-wall carbon nanotube surface. Open Mater Sci J. 5:242–247.
  • Zheng Y, Cai Z, Song X, Chen Q, Bi Y, Li Y, Hou S. 2009. Preparation and characterization of folate conjugated N-trimethyl chitosan nanoparticles as protein carrier targeting folate receptor: in vitro studies. J Drug Target. 17:294–303.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.